Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
39.83
+2.72 (7.33%)
At close: Jun 16, 2025, 4:00 PM
39.23
-0.60 (-1.51%)
After-hours: Jun 16, 2025, 7:58 PM EDT
Claritev Market Cap
Claritev has a market cap or net worth of $654.66 million as of June 16, 2025. Its market cap has increased by 74.85% in one year.
Market Cap
654.66M
Enterprise Value
5.27B
1-Year Change
74.85%
Ranking
Category
Stock Price
$39.83
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $654.66M, an increase of 169.41%. That is a compound annual growth rate of 21.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 609.95M | 155.20% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.99B |
| Johnson & Johnson | 373.47B |
| Novo Nordisk | 343.59B |
| AbbVie | 337.14B |
| UnitedHealth Group | 279.09B |
| Abbott Laboratories | 233.16B |
| Novartis AG | 232.80B |
| AstraZeneca | 228.09B |